Placebo to Keytruda - Normal Saline Solution, GEMCITABINE, CISPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion
MK-3475-866
Phase 3 small_molecule active
Quick answer
Placebo to Keytruda - Normal Saline Solution, GEMCITABINE, CISPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Cis-eligible Muscle-invasive bladder cancer. is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Cis-eligible Muscle-invasive bladder cancer.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active